5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.59▼ | 4.59▼ | 4.59▼ | 4.94▼ | 4.91▼ |
MA10 | 4.81▼ | 4.82▼ | 4.86▼ | 5.03▼ | 4.33▲ |
MA20 | 5.16▼ | 5.14▼ | 5.16▼ | 4.97▼ | 6.28▼ |
MA50 | 5.33▼ | 5.09▼ | 4.96▼ | 4.32▲ | 69.89▼ |
MA100 | 5.08▼ | 4.98▼ | 4.74▼ | 6.61▼ | N/A |
MA200 | 4.98▼ | 4.43▼ | 5.16▼ | 41.78▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.098▼ | -0.112▼ | -0.131▼ | -0.047▼ | 8.561▲ |
RSI | 23.192▼ | 29.096▼ | 33.771▼ | 46.740▼ | 28.416▼ |
STOCH | 1.190▼ | 0.862▼ | 0.505▼ | 29.922 | 41.102 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -85.214▼ | -66.260 |
CCI | -134.287▼ | -126.922▼ | -122.003▼ | -110.901▼ | 24.428 |
Monday, June 09, 2025 05:00 PM
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies ...
|
Wednesday, May 14, 2025 01:15 PM
Despite concerns over the company’s decision to implement widespread store closures due to new Pharmacy Benefit Management (PBM) reform legislation, market sentiment remains positive.
|
Thursday, May 01, 2025 04:30 AM
New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 4.60 | 4.675 | 4.35 | 4.54 | 38,500 |
12/06/25 | 4.95 | 5.363 | 4.635 | 4.635 | 27,070 |
11/06/25 | 5.1927 | 5.1999 | 4.7214 | 4.97 | 36,125 |
10/06/25 | 5.31 | 5.31 | 5.06 | 5.14 | 42,483 |
09/06/25 | 5.80 | 6.00 | 5.365 | 5.395 | 59,500 |
06/06/25 | 5.10 | 5.684 | 5.10 | 5.52 | 70,700 |
05/06/25 | 5.48 | 5.80 | 5.075 | 5.10 | 100,800 |
04/06/25 | 4.8601 | 5.78 | 4.74 | 5.48 | 79,488 |
03/06/25 | 4.54 | 5.09 | 4.5165 | 4.8849 | 64,633 |
02/06/25 | 4.7699 | 5.1999 | 4.618 | 4.64 | 93,281 |
|
|
||||
|
|
||||
|
|